drugset / Trial / NCT01341717
Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to determine the efficacy and safety of sitaglipin in the treatment of Type 2 diabetes mellitus (T2DM) patients with inadequate glycemic control using metformin and insulin.
Timeline
- Start
- 2012-02
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glimepiride | Small molecule | 1 mg | — |
| Subject | Glimepiride | Small molecule | 2 mg | — |
| Subject | Glimepiride | Small molecule | 3 mg | — |
| Subject | Sitagliptin | Small molecule | 100 mg | — |
| Background | Insulin | Protein / enzyme biologic | 10 iu | — |
| Background | Metformin | Small molecule | 1000 mg | — |